Johnson & Johnson, a global leader in the pharmaceutical and healthcare industry, is committed to delivering innovative solutions that improve patient lives. Their Distribution Centre in Beerse, Belgium, plays a vital role in shipping clinical trial materials across the EU and globally.
Clinical sites experienced unnecessary waste and handling difficulties due to single-use shippers.
The size and weight of existing shippers created handling inefficiencies and added ergonomic and storage concerns across internal operations.
A fragmented global shipper portfolio lacked standardization and reusability.
With J&J, Bluecrux optimized the passive shipper strategy at Beerse Distribution Centre, cutting costs and emissions while meeting strict pharma cold-chain standards.
A global RFP process was launched to identify a supplier offering reusable, high-performance shipping containers.
A global leader was selected as a supplier for their superior ambient and cold chain solutions.
Implementation involved:
Switching from single-use to reusable shippers for EU-27 shipments.
Introducing a reverse logistics process to return and refurbish used shippers.
3x reduction in temperature excursions, improving patient and site experience.
93% return rate of reusable shippers, with 80% picked up within one business day.
Reusability rate rose from 58% to 84%, driving significant sustainability impact.
Estimated 50% reduction in landfill waste and 45% reduction in carbon footprint.
$2 million saved in freight costs due to optimized volume and weight.
Improved ergonomics and handling for warehouse and clinical site staff.
Harmonized shipper portfolio globally, setting the stage for potential worldwide expansion.
Storage, packaging, monitoring, transport, customs, product handling, delivery.
Keep track of your cold chain and address issues before it’s too late.
Setup planning solutions to balance demand and supply of cold chain capacity.
